Early Detection of Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer
Background Epirubicin is a cytotoxic drug, widely used in patients with breast cancer, but its application is limited by its cardiotoxicity. Assessment of left ventricular (LV) ejection fraction (EF) is…